Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Role of SABR in Head and Neck Cancer: Results From a Multi-institutional Delphi Consensus.

International journal of radiation oncology, biology, physics·2026
Same author

Paediatric Epstein-Barr virus-associated intracranial smooth muscle tumours.

Singapore medical journal·2026
Same author

Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: A Case-Based Radiosurgery Society Review.

Practical radiation oncology·2026
Same author

Shaping the future of blood management in metastatic spine tumor surgery: the case for cell-salvaged transfusion with a propensity-matched study.

North American Spine Society journal·2026
Same author

Leveraging 3D Printing-Induced Spherulitic Topographical and Biochemical Cues on Polyether Ether Ketone/Hydroxyapatite/Magnesium Orthosilicate Composites for Orthopedic Applications.

ACS applied materials & interfaces·2026
Same author

Clinical practice, barriers to implementation, and priorities for equitable access of Stereotactic Body Radiation Therapy: An analysis of the global status by the ESTRO SBRT Focus Group.

Clinical and translational radiation oncology·2026

Related Experiment Video

Updated: Jul 11, 2025

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.0K

Intracranial Germ Cell Tumors.

Teri Danielle You Ying Yeoh1, Vincent Nga2, Miriam Kimpo3

  • 1Department of Radiation Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore.

Seminars in Neurology
|November 14, 2023
PubMed
Summary

Intracranial germ cell tumors in young adults show high survival rates with modern treatments. Advances in diagnosis and therapy improve outcomes while reducing toxicity for these rare cancers.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Related Experiment Videos

Last Updated: Jul 11, 2025

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.0K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Rare Cancers

Background:

  • Intracranial germ cell tumors (IGCTs) are rare, affecting adolescents and young adults.
  • IGCTs include germinomas and non-germinomatous germ cell tumors (NGGCTs).
  • Recent decades saw improved survival and reduced toxicity through cooperative group trials.

Purpose of the Study:

  • To review current strategies for treating IGCTs.
  • To highlight advancements in diagnosis and therapy.
  • To discuss survival outcomes and future directions.

Main Methods:

  • Review of cooperative trial group data from Europe and North America.
  • Analysis of treatment strategies including surgery, chemotherapy, and radiation therapy.
  • Evaluation of diagnostic advancements reducing the need for radical surgery.

Main Results:

  • 5-year event-free survival (EFS) exceeds 90% for germinomas, even with metastatic disease.
  • Combined modality treatment (surgery, chemotherapy, radiotherapy) is tailored by staging.
  • For NGGCTs, neoadjuvant chemotherapy followed by surgery and radiotherapy yields a 5-year EFS of 70%.

Conclusions:

  • Current treatment strategies significantly improve survival for IGCTs.
  • Focus is shifting towards minimizing long-term treatment complications.
  • Preserving high cure rates remains paramount in IGCT management.